Invesco Ltd. Vericel Corp Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Vericel Corp stock. As of the latest transaction made, Invesco Ltd. holds 2,368,229 shares of VCEL stock, worth $146 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,368,229

Previous 1,799,183 31.63%

Holding current value

$146 Million

Previous $82.5 Million 21.21%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$42.25 - $53.56 $24 Million - $30.5 Million	569,046 Added 31.63%	2,368,229 $100 Million
Q2 2024 Aug 13, 2024	BUY	$41.71 - $52.9 $53.5 Million - $67.8 Million	1,282,191 Added 248.01%	1,799,183 $82.5 Million
Q1 2024 May 14, 2024	BUY	$32.52 - $52.33 $5.68 Million - $9.15 Million	174,789 Added 51.08%	516,992 $26.9 Million
Q4 2023 Feb 12, 2024	SELL	$30.85 - $37.09 $1.04 Million - $1.25 Million	-33,739 Reduced 8.97%	342,203 $12.2 Million
Q3 2023 Nov 13, 2023	SELL	$31.69 - $39.25 $1.19 Million - $1.47 Million	-37,545 Reduced 9.08%	375,942 $12.6 Million
Q2 2023 Aug 11, 2023	SELL	$29.0 - $38.37 $780,854 - $1.03 Million	-26,926 Reduced 6.11%	413,487 $15.5 Million
Q1 2023 May 12, 2023	SELL	$23.85 - $31.34 $2.09 Million - $2.74 Million	-87,577 Reduced 16.59%	440,413 $12.9 Million
Q4 2022 Feb 13, 2023	BUY	$17.65 - $27.37 $1.28 Million - $1.98 Million	72,285 Added 15.86%	527,990 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $5.59 Million - $8.04 Million	247,091 Added 118.44%	455,705 $10.6 Million
Q2 2022 Aug 15, 2022	SELL	$22.88 - $39.45 $4.43 Million - $7.65 Million	-193,816 Reduced 48.16%	208,614 $5.25 Million
Q1 2022 May 16, 2022	SELL	$31.69 - $43.29 $2.58 Million - $3.53 Million	-81,433 Reduced 16.83%	402,430 $15.4 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $52.6 $1.38 Million - $2.06 Million	39,174 Added 8.81%	483,863 $19 Million
Q3 2021 Nov 15, 2021	BUY	$46.35 - $59.75 $558,054 - $719,390	12,040 Added 2.78%	444,689 $21.7 Million
Q2 2021 Aug 17, 2021	SELL	$47.2 - $67.81 $12.1 Million - $17.4 Million	-256,976 Reduced 37.26%	432,649 $22.7 Million
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $12.4 Million - $23.8 Million	400,146 Added 138.23%	689,625 $38.3 Million
Q4 2020 Feb 16, 2021	BUY	$18.53 - $31.5 $5.18 Million - $8.8 Million	279,421 Added 2778.1%	289,479 $8.94 Million
Q3 2020 Nov 16, 2020	SELL	$14.68 - $19.12 $6.49 Million - $8.46 Million	-442,393 Reduced 97.78%	10,058 $186,000
Q2 2020 Aug 14, 2020	BUY	$8.5 - $15.82 $3.75 Million - $6.98 Million	441,505 Added 4033.48%	452,451 $6.25 Million
Q1 2020 May 15, 2020	BUY	$7.25 - $19.22 $79,358 - $210,382	10,946 New	10,946 $100,000
Q4 2019 Feb 14, 2020	SELL	$13.77 - $19.2 $741,335 - $1.03 Million	-53,837 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$14.93 - $19.83 $803,786 - $1.07 Million	53,837 New	53,837 $815,000
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $3.85 Million - $4.84 Million	-256,169 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$16.23 - $20.29 $2.57 Million - $3.22 Million	-158,513 Reduced 38.23%	256,169 $4.49 Million
Q4 2018 Feb 14, 2019	BUY	$10.77 - $18.44 $4.47 Million - $7.65 Million	414,682 New	414,682 $7.22 Million

Others Institutions Holding VCEL

# of Institutions

285

Shares Held

49.3M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.92B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account